-
A good vaccine against HIV comes in threes Development of a vaccine against HIV is a real feat. Rogier Sanders, professor of Virology, in particular Experimental Vaccinology, has been working on a shot like this for years.Nieuws
-
Discovery of new more infectious HIV variant A new variant of HIV has been discovered that causes more rapid onset of the disease. The new HIV strain was discovered in more than 100 people using data from the Netherlands.Nieuws
-
Temporary benefit for immune system in early HIV treatment, but dysregulation returns Despite effective HIV medication, the immune system of people with HIV remains disrupted in the long term. Researchers at Amsterdam UMC investigated whether this dysregulation can be prevented by starting HIV medication immediately after infection – i.e. within a few days. They saw that six months after this early treatment, the immune system did indeed work as in people without HIV. But in the longer term, the immune system was disrupted again. This is shown by research by Amsterdam UMC, published in the journal EBioMedicine.Nieuws
-
Proof of concept for Amsterdam UMC-led HIV vaccination Worldwide, an estimated 40 million people live with HIV, two-thirds living on the African continent. In 2023, more than 600,000 people died from HIV-related causes and 1.32 million became infected. There is no vaccine against the world's second most deadly infection – only tuberculosis kills more people. However, researchers from Amsterdam UMC have taken an important step towards reaching the goal of an HIV vaccine. The results of their phase one trial are published today in Science.Nieuws
-
Priming, Shaping and Polishing: In search of a HIV Vaccine Worldwide, an estimated, 40 million people live with HIV. Two-thirds of this group on the African continent. In 2022, more than 600,000 people died from HIV-related causes and more than 1.3 million were infected. There is no vaccine against the world's second most deadly infection, after TB. Thanks to a grant from the Bill & Melinda Gates Foundation, Amsterdam UMC's Rogier Sanders leads a project that aims to develop the first effective HIV vaccine.Nieuws
-
In search of a cure for HIV for the group that are hit the hardest A universal solution to the HIV epidemic, regardless of what type of virus the patient has. That is the ambition of Dutch and African researchers in the SPIRAL-project. They recently received a grant of more than 6 million euros from the Netherlands Organisation for Scientific Research (NWO) and the AidsFonds.Nieuws
-
AII symposium – Other abstracts presentation parallel session - Infectious DiseasesDownloadspdf | 584 kbDownload
-
AII 5th Annual Symposium, Other abstracts without presentation, Infectious DiseasesDownloadspdf | 696 kbDownload
U heeft gezocht op ‘hiv’.
Dat leverde 65 resultaten op.
65